MELD and MELD-Na Scoring Systems
MELD (Model for End-Stage Liver Disease) is an objective scoring system that uses three laboratory values—serum bilirubin, creatinine, and INR—to predict 3-month mortality risk in patients with end-stage liver disease, while MELD-Na incorporates serum sodium into this calculation to improve prognostic accuracy, particularly for patients with hyponatremia. 1
What is MELD?
MELD was originally developed to predict short-term survival in patients undergoing TIPS (transjugular intrahepatic portosystemic shunt) procedures for gastrointestinal bleeding 1. Since 2002, it has been adopted worldwide as the primary tool for prioritizing patients on liver transplant waiting lists 1.
MELD Calculation Components:
- Serum bilirubin (mg/dL)
- Serum creatinine (mg/dL)
- INR (International Normalized Ratio of prothrombin time)
The score ranges from 6 (less ill) to 40 (gravely ill), with higher scores indicating greater mortality risk 2, 3, 4.
Clinical Significance:
- MELD ≥15: Recommended threshold for listing patients for liver transplantation 1
- MELD <15: One-year survival is actually lower WITH transplantation compared to without it 1
- MELD >30: Significant risk of mortality and morbidity after transplantation must be carefully addressed 1
- MELD >35: The score begins to predict post-transplant mortality 1
What is MELD-Na?
MELD-Na incorporates serum sodium levels into the MELD calculation to enhance its predictive accuracy 1. This modification was proposed because hyponatremia is an independent predictor of mortality in cirrhotic patients and improves the model's ability to stratify risk 5, 6.
Why Sodium Matters:
Patients with cirrhosis and hyponatremia have worse outcomes, and the original MELD score did not capture this risk. Studies demonstrate that MELD-Na consistently shows higher area under the receiver operating characteristic curve (AUC) compared to MELD alone (0.908 vs 0.823, p=0.004) 5. The integrated MELD (iMELD) and MELD-Na both outperform standard MELD for outcome prediction 6.
Key Clinical Applications
For Liver Transplantation:
- MELD is the primary tool for organ allocation in most countries, prioritizing sicker patients based on objective laboratory values rather than waiting time 1
- MELD-Na provides better mortality prediction and is increasingly used for allocation decisions 1
- The score predicts short-term pre-transplant mortality risk effectively 1
Beyond Transplantation:
MELD scores accurately predict outcomes in:
- Patients with cirrhosis undergoing surgery 3, 4
- Alcoholic hepatitis 3, 4
- Variceal hemorrhage 4
- Hepatorenal syndrome 4
- Acute decompensated hepatitis 5
Important Limitations and Exceptions
MELD Has Several Recognized Limitations:
Clinical conditions not captured by MELD that still warrant transplantation include 1:
- Hepatopulmonary syndrome
- Portopulmonary hypertension
- Recurrent or chronic hepatic encephalopathy
- Refractory ascites
- Recurrent gastrointestinal bleeding
- Intractable pruritus
- Hepatocellular carcinoma (HCC)
- Cholangiocarcinoma
- Metabolic diseases (amyloidosis, primary hyperoxaluria, etc.)
For these MELD exceptions, extra points are added to give patients appropriate priority for transplantation 1. For HCC specifically, additional points depend on tumor size, number of nodules, AFP levels, waiting time, and response to downstaging therapy 1.
Gender Disparity Issues:
Women experience significant disadvantages with MELD-based allocation 7:
- 17-30% less likelihood of receiving transplant compared to men
- 30% greater likelihood of dying on the waiting list
- Serum creatinine underestimates renal dysfunction in women
MELD 3.0 was developed to address this by incorporating sex and albumin into the calculation, crediting women an extra 1.3 points on average and reducing waiting list deaths 7, 8, 9.
Practical Considerations
Delta MELD:
The change in MELD over time (ΔMELD) may be a better predictor of mortality than a single measurement 1.
Measurement Method Matters:
Direct vs. indirect ion-selective electrode methods for measuring sodium can produce different MELD-Na scores, potentially affecting waiting list position 10. This is particularly relevant in cirrhotic patients with hypoproteinemia.
For DCD (Donation after Circulatory Death) Grafts:
Matching controlled DCD livers to recipients with MELD <25 is recommended due to higher risk of reperfusion injury and complications in sicker recipients 11.
Common Pitfalls to Avoid
Don't use MELD <15 as indication for transplant listing—these patients have better survival without transplantation 1
Don't ignore MELD exceptions—many life-threatening complications of cirrhosis aren't reflected in the score and require expert assessment 1
Don't apply MELD when INR or creatinine are elevated from non-hepatic causes—the score loses accuracy 3
Don't use recipient MELD as sole criterion for accepting/rejecting a DBD (donation after brain death) graft—evidence is conflicting 11
Recognize that MELD is inaccurate in 15-20% of cases and clinical judgment remains essential 4